Universidad Nacional de Salta   Report issue

Academic/Hospital Phase 2
Founded: Salta Argentina (1972)

Organization Overview

First Clinical Trial
2010
NCT01308268
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Alejandro Krolewiecki | Universidad Nacional de Salta | Universidad Nacional de Salta, Instituto de Investigación en Enfermedades Tropicales

Active Ingredients

Drugs in Phase 2 Trials (2)

albendazole (Albenza) (5 trials)

ivermectin (stromectol) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Helminthiasis (Phase 2)

Trichuriasis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 2